NIO Glioma Reveal
Commercial- Indications
- Glioma
Company intelligence / Profile preview
Invenio Imaging has developed the NIO Laser Imaging System, which enables real-time, stain-free histologic imaging of fresh tissue during surgery. The system leverages stimulated Raman histology and artificial intelligence to provide rapid digital images for intraoperative decision-making. It has been used in over 2,000 cases across the US and Europe. Their AI-based image analysis module recently received FDA Breakthrough Device Designation for assisting with bronchoscopic lung biopsies[1][3].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invenio Imaging.